SEC Form D · filed July 22, 2021
Akari Therapeutics Plc
Location
LONDON, United Kingdom
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
James Hill · London, United KingdomDirectorClive Richardson · London, United KingdomExec · DirectorMichael Grissinger · London, United KingdomDirectorPeter Feldschreiber · London, United KingdomDirectorStuart Ungar · London, United KingdomDirectorDavid Byrne · London, United KingdomDirectorRay Prudo · London, United KingdomDirectorDonald Williams · London, United KingdomDirectorGerard Cuddy · Irvine, CADirectorJeffrey O'Donohue · TOLUCA LAKE, CADirectorAike Ho · Oakland, CADirectorSara Y. Huda · Grand Duchy of Luxembourg, LuxembourgDirectorEslie C. Sykes · Raleigh, NCExec · DirectorPeter Feldschreiber · London, United KingdomDirectorEric Wiesen · Oakland, CADirectorJeffrey Zhao · West Hollywood, CADirectorMariel A. Joliet · HOUSTON, TXDirectorGeorge E. Marucci, Jr · HOUSTON, TXDirectorSusan C. Schnabel · HOUSTON, TXDirectorDouglas L. Goodwillie · HOUSTON, TXDirectorKenneth B. Leonard · HOUSTON, TXExec · DirectorTerry A. Hart · HOUSTON, TXDirectorMichael J. O'Neil · HOUSTON, TXDirectorJohn B. Riley · HOUSTON, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗